文献速递血栓与止血

JTH临床专栏:儿童静脉血栓栓塞症(VTE)风险患者的预防策略

JTH in Clinic: Venous Thromboembolism (VTE) Prophylaxis of Pediatric Patients at Risk of VTE.
PubMed 文献 · J Thromb Haemost · 2026-10-26

住院儿童VTE发病率上升,但预防策略因儿科数据有限而实践不一。近期随机临床试验和 multicenter 观察性研究提供了抗凝药在特定儿科亚群中预防VTE的安全性和有效性证据,支持开发风险评价模型。美国血液学会和国际血栓与止血学会据此制定了首部儿童VTE抗凝预防的循证指南。本文以病例为基础,应用新指南和支持证据指导临床常见儿科病例的血栓预防决策,强调危重儿童VTE预防的细微差别。

要点

  • 住院儿童VTE发病率上升,需改进预防策略。
  • 近期随机临床试验和观察性研究为特定儿科亚群抗凝预防提供证据。
  • ASH和ISTH已制定首部儿童VTE抗凝预防循证指南。

核心结论

  • ASH和ISTH基于近期证据制定了首部儿童VTE抗凝预防循证指南,但儿科VTE预防仍因年龄相关生理变化和独特风险因素而复杂。

研究设计与样本

  • 本文为基于病例的综述,应用新指南和支持证据指导临床常见儿科病例的血栓预防决策。

主要发现

  • 近期随机临床试验和设计良好的多中心观察性研究提供了抗凝药在特定儿科亚群中预防VTE的安全性和有效性证据。
  • 这些数据支持开发风险评价模型以识别VTE高风险儿童亚群。

关键数值与推荐

  • 美国血液学会和国际血栓与止血学会近期制定了首部儿童VTE风险患者抗凝预防的循证指南。

临床怎么用

  • 应用新指南和支持证据指导儿科病例的血栓预防决策,包括评估VTE风险、出血风险及与家庭共同决策。
  • 强调多学科团队在VTE预防和抗凝药物管理中的重要性,以及儿科与成人实践的异同。

局限性

  • 儿科特异性数据有限,且缺乏直到最近的循证指南。
  • 儿科独特的风险因素和随年龄变化的生理导致VTE和出血风险异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

As the incidence of venous thromboembolism (VTE) increases in hospitalized children, there is an urgent need to improve VTE prevention strategies in this population. Implementation of thromboprophylaxis, which includes mechanical and pharmacological interventions, varies in practice due to limited pediatric-specific data and, until recently, a lack of evidence-based guidelines. However, recent randomized clinical trials and well-designed multicenter observational studies have provided improved evidence on the safety and efficacy of anticoagulants for VTE prevention in specific pediatric subpopulations supporting the development of risk assessment models to help identify subgroups of children at high risk for VTE. Based on these data, the American Society of Hematology and International Society on Thrombosis and Haemostasis recently developed the first evidence-based guideline for anticoagulant prophylaxis in children at risk of VTE. While this guideline is an exciting step towards preventing VTE-associated harm, VTE prevention remains complex due to unique pediatric risk factors and changing physiology with age, resulting in heterogeneous VTE and bleeding risk profiles. In this case-based review, we apply the new guideline and supporting evidence to guide decisions regarding the use of thromboprophylaxis in pediatric cases commonly encountered in clinical practice, highlighting the nuances of VTE prevention in critically ill children. We review the complex decision-making process required prior to initiation of pharmacologic prophylaxis, including assessment of VTE risk, bleeding risk, and shared decision-making with families. Additionally, we highlight the importance of multidisciplinary teams in VTE prevention and anticoagulant stewardship, as well as the similarities and differences in pediatric versus adult practice.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Whitworth H, Connor SM, Gilmore H, et al. JTH in Clinic: Venous Thromboembolism (VTE) Prophylaxis of Pediatric Patients at Risk of VTE. J Thromb Haemost. 2026. PMID: 42933654. doi:10.1016/j.jtha.2026.10.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。